menu ☰
menu ˟

CARB-X grants T2 Biosystems up to $2 million for antimicrobial resistance research

11 Mar 2018
The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X, granted T2 Biosystems Inc. up to $2 million to develop new tests that can detect bacterial pathogens and resistance markers directly in whole blood, according to a ...

Click here to view the full article which appeared in Nursing

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.